Skip to content
The Policy VaultThe Policy Vault

PonvoryCigna

multiple sclerosis

Preferred products

  • generic fingolimod capsules
  • generic dimethyl fumarate delayed-release capsules

Initial criteria

  • Patient meets BOTH of the following (A and B):
  • A) Patient meets the standard Multiple Sclerosis – Ponvory Prior Authorization Policy criteria; AND
  • B) Patient meets ONE of the following (i or ii):
  • i. Patient has been established on Ponvory for ≥ 120 days; OR
  • ii. Patient meets BOTH of the following (a and b):
  • a) Patient meets BOTH of the following [(1) and (2)]:
  • (1) Patient has tried generic dimethyl fumarate delayed-release capsules [documentation required]; AND
  • (2) Patient has experienced inadequate efficacy or significant intolerance according to the prescriber [documentation required];
  • b) Patient meets BOTH of the following [(1) and (2)]:
  • (1) Patient has tried generic fingolimod capsules [documentation required]; AND
  • (2) Patient has experienced inadequate efficacy or significant intolerance according to the prescriber [documentation required].

Approval duration

1 year